Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmacogenomics J ; 21(1): 47-59, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-32683419

RESUMO

Inter-individual variation of drug metabolising enzymes (DMEs) leads to variable efficacy of many drugs and even adverse drug responses. Consequently, it would be desirable to test variants of many DMEs before drug treatment. Inter-ethnic differences in frequency mean that the choice of SNPs to test may vary across population groups. Here we examine the utility of testing representative groups as a way of assessing what variants might be tested. We show that publicly available population information is potentially useful for determining loci for pre-treatment genetic testing, and for determining the most prevalent risk haplotypes in defined groups. However, we also show that the NHS England classifications have limitations for grouping for these purposes, in particular for people of African descent. We conclude: (1) genotyping of hospital patients and people from the hospital catchment area confers no advantage over using samples from appropriate existing ethnic group collections or publicly available data, (2) given the current NHS England Black African grouping, a decision as to whether to test, would have to apply to all patients of recent Black African ancestry to cover reported risk alleles and (3) the current scarcity of available genome and drug effect data from Africans is a problem for both testing and treatment decisions.


Assuntos
Etnicidade/genética , Inativação Metabólica/genética , Farmacogenética , Testes Farmacogenômicos , Alelos , Arilamina N-Acetiltransferase/genética , População Negra/genética , Citocromo P-450 CYP2C19/genética , Citocromo P-450 CYP2C9/genética , Citocromo P-450 CYP3A/genética , Inglaterra/epidemiologia , Feminino , Genótipo , Glucuronosiltransferase/genética , Haplótipos/genética , Humanos , Masculino , Oxigenases/genética , Polimorfismo de Nucleotídeo Único/genética , Medicina Estatal , População Branca/genética
2.
Amyotroph Lateral Scler ; 13(4): 341-6, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22409358

RESUMO

While some cases of familial ALS can be entirely attributed to known inherited variation, the majority (∼ 90%) are sporadic, where the cause(s) are not entirely understood. Both genetic and environmental factors may contribute to susceptibility. Mitochondrial damage, a common feature of neurodegenerative disease, is observed in most patients and inherited polymorphism in the mitochondrial genome has been suggested as a contributing factor. We used an economic and efficient method to test whether such involvement is probable. We genotyped 22 mtDNA coding region SNPs and sequenced the mtDNA hypervariable region 1 to determine the position of each mitochondrial genome within the genealogy of mitochondrial haplotypes in samples of ALS patients (n = 700) and controls (n = 462) from two European populations. We compared haplotype and haplogroup distribution in cases and controls drawn from the same populations. No statistical difference was observed between cases and controls at either the haplogroup or haplotype level (p = ≥ 0.2). In conclusion, it is unlikely that common, shared genetic variants in the mitochondrial genome contribute substantially to ALS. Combining the data with other studies will allow meta-analysis to look for variants with modest effect sizes. The sequencing of complete mitochondrial genomes will be required to assess the role of rare mutations.


Assuntos
Esclerose Lateral Amiotrófica/genética , DNA Mitocondrial/genética , Predisposição Genética para Doença , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Estudos de Coortes , Feminino , Estudos de Associação Genética , Genoma Mitocondrial , Genótipo , Haplótipos , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , População Branca/genética
3.
BMC Evol Biol ; 10: 36, 2010 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-20144208

RESUMO

BACKGROUND: The ability of adult humans to digest the milk sugar lactose - lactase persistence - is a dominant Mendelian trait that has been a subject of extensive genetic, medical and evolutionary research. Lactase persistence is common in people of European ancestry as well as some African, Middle Eastern and Southern Asian groups, but is rare or absent elsewhere in the world. The recent identification of independent nucleotide changes that are strongly associated with lactase persistence in different populations worldwide has led to the possibility of genetic tests for the trait. However, it is highly unlikely that all lactase persistence-associated variants are known. Using an extensive database of lactase persistence phenotype frequencies, together with information on how those data were collected and data on the frequencies of lactase persistence variants, we present a global summary of the extent to which current genetic knowledge can explain lactase persistence phenotype frequency. RESULTS: We used surface interpolation of Old World lactase persistence genotype and phenotype frequency estimates obtained from all available literature and perform a comparison between predicted and observed trait frequencies in continuous space. By accommodating additional data on sample numbers and known false negative and false positive rates for the various lactase persistence phenotype tests (blood glucose and breath hydrogen), we also apply a Monte Carlo method to estimate the probability that known lactase persistence-associated allele frequencies can explain observed trait frequencies in different regions. CONCLUSION: Lactase persistence genotype data is currently insufficient to explain lactase persistence phenotype frequency in much of western and southern Africa, southeastern Europe, the Middle East and parts of central and southern Asia. We suggest that further studies of genetic variation in these regions should reveal additional nucleotide variants that are associated with lactase persistence.


Assuntos
Digestão , Variação Genética , Lactase/genética , Lactase/metabolismo , Lactose/metabolismo , Adulto , África , Ásia , Bases de Dados Genéticas , Europa (Continente) , Frequência do Gene , Genética Populacional , Geografia , Humanos
4.
J Mol Evol ; 69(6): 579-88, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19937006

RESUMO

Persistence of intestinal lactase into adulthood allows humans to use milk from other mammals as a source of food and water. This genetic trait has arisen by convergent evolution and the derived alleles of at least three different single nucleotide polymorphisms (-13910C>T, -13915T>G, -14010G>C) are associated with lactase persistence in different populations. Each allele occurs on an extended haplotype, consistent with positive directional selection. The SNPs are located in an 'enhancer' sequence in an intron of a neighboring gene (MCM6) and modulate lactase transcription in vitro. However, a number of lactase persistent individuals carry none of these alleles, but other low-frequency single nucleotide polymorphisms have been observed in the same region. Here we examine a cohort of 107 milk-drinking Somali camel-herders from Ethiopia. Eight polymorphic sites are identified in the enhancer. -13915*G and -13907*G (a previously reported candidate) are each significantly associated with lactase persistence. A new allele, -14009*G, has borderline association with lactase persistence, but loses significance after correction for multiple testing. Sequence diversity of the enhancer is significantly higher in the lactase persistent members of this and a second cohort compared with non-persistent members of the two groups (P = 7.7 x 10(-9) and 1.0 x 10(-3)). By comparing other loci, we show that this difference is not due to population sub-structure, demonstrating that increased diversity can accompany selection. This contrasts with the well-documented observation that positive selection decreases diversity by driving up the frequency of a single advantageous allele, and has implications for association studies.


Assuntos
Alelos , População Negra/genética , Variação Genética , Lactase/genética , Intolerância à Lactose/etnologia , Intolerância à Lactose/genética , Animais , Estudos de Coortes , Elementos Facilitadores Genéticos , Etiópia/etnologia , Etnicidade/etnologia , Etnicidade/genética , Evolução Molecular , Frequência do Gene , Genética Populacional , Genótipo , Humanos , Lactase/metabolismo , Intolerância à Lactose/enzimologia , Leite/metabolismo , Fenótipo , Polimorfismo de Nucleotídeo Único , Seleção Genética , Somália
5.
Hum Genet ; 124(6): 579-91, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19034520

RESUMO

It has been known for some 40 years that lactase production persists into adult life in some people but not in others. However, the mechanism and evolutionary significance of this variation have proved more elusive, and continue to excite the interest of investigators from different disciplines. This genetically determined trait differs in frequency worldwide and is due to cis-acting polymorphism of regulation of lactase gene expression. A single nucleotide polymorphism located 13.9 kb upstream from the lactase gene (C-13910 > T) was proposed to be the cause, and the -13910*T allele, which is widespread in Europe was found to be located on a very extended haplotype of 500 kb or more. The long region of haplotype conservation reflects a recent origin, and this, together with high frequencies, is evidence of positive selection, but also means that -13910*T might be an associated marker, rather than being causal of lactase persistence itself. Doubt about function was increased when it was shown that the original SNP did not account for lactase persistence in most African populations. However, the recent discovery that there are several other SNPs associated with lactase persistence in close proximity (within 100 bp), and that they all reside in a piece of sequence that has enhancer function in vitro, does suggest that they may each be functional, and their occurrence on different haplotype backgrounds shows that several independent mutations led to lactase persistence. Here we provide access to a database of worldwide distributions of lactase persistence and of the C-13910*T allele, as well as reviewing lactase molecular and population genetics and the role of selection in determining present day distributions of the lactase persistence phenotype.


Assuntos
Evolução Molecular , Lactase/genética , Lactase/metabolismo , Lactose/metabolismo , África , Alelos , Sequência de Bases , Proteínas de Ciclo Celular/genética , Digestão/genética , Genética Populacional , Haplótipos , Humanos , Intolerância à Lactose/enzimologia , Intolerância à Lactose/genética , Teste de Tolerância a Lactose , Componente 6 do Complexo de Manutenção de Minicromossomo , Dados de Sequência Molecular , Polimorfismo de Nucleotídeo Único
6.
Clin Chim Acta ; 392(1-2): 58-62, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18396155

RESUMO

BACKGROUND: Adult-type hypolactasia is a genetically determined inability to digest lactose after weaning. Two single-nucleotide polymorphisms (C-13910T, G-22018A) located upstream of the lactase gene (LCT) within the gene MCM6 are associated with the lactase persistence/non-persistence trait in patients of European descent. Therefore, the genotyping of these SNPs has been established as a diagnostic tool for adult-type hypolactasia. We have recently shown that several novel allelic variants located in close proximity to the C-13910T SNP interfere with the diagnostic accuracy of real-time PCR-based genotyping methods. METHODS: We describe here the validation of a comprehensive reverse-hybridization teststrip-based assay for the detection of common and novel LCT SNPs (C-13907G, C-13910T, T-13913C, G-13914A, T-13915G, and G-22018A). This assay is based on multiplex DNA amplification and ready-to-use membrane teststrips containing variant-specific oligonucleotide probes immobilized as an array of parallel lines. RESULTS: We evaluated the novel reverse-hybridization StripAssay on 125 DNA samples in comparison to LightCycler analysis and sequencing. The outcome of StripAssay genotyping was found to be completely concordant with that obtained by sequencing. CONCLUSIONS: The StripAssay represents an accurate and robust screening tool to identify multiple LCT/MCM6 variants in a rapid manner. It overcomes diagnostic pitfalls that were reported and allows the simultaneous genotyping of closely spaced LCT variant sites in a single-step diagnostic approach.


Assuntos
Lactase/genética , Intolerância à Lactose/diagnóstico , Hibridização de Ácido Nucleico/métodos , Alelos , Áustria/epidemiologia , Frequência do Gene , Genótipo , Humanos , Intolerância à Lactose/epidemiologia , Intolerância à Lactose/genética , Polimorfismo de Nucleotídeo Único
7.
Clin Chim Acta ; 384(1-2): 93-8, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17651714

RESUMO

BACKGROUND: Patients presenting with symptoms of lactose intolerance are in some centres routinely tested for a single-nucleotide polymorphism C-13910T, which is located upstream of the lactase gene (LCT) and is tightly associated with genetically determined lactase persistence/non-persistence. Typing of this polymorphism enables differential diagnosis for genetic versus secondary causes of lactose intolerance. Several PCR-based methods have been established as tests for this SNP. In particular, automated genotyping assays conducted on LightCycler platforms provide a rapid, labour-saving means for routine high-throughput analysis of this variant. Recently, several novel allelic variants have been identified in non-European populations. Three of these variants occur in close proximity to C-13910T, but their effect on the genetic test is unknown. METHODS: Here we analyse whether the occurrence of C-13907G, T-13913C, and T-13915G, affect the diagnostic accuracy of C-13910T typings obtained using the LightCycler MutaREAL lactase real-time PCR kit. RESULTS: Genotyping of DNA samples harbouring respective variants or combinations thereof significantly influenced the LightCycler analysis. Some allelic combinations generated melting profiles that prevented the correct assignment of C-13910T. CONCLUSIONS: We conclude that genotyping of the C-13910T variant with the MutaREAL lactase real-time PCR kit in non-Europeans is prone to error and should be omitted.


Assuntos
Lactase/genética , Intolerância à Lactose/diagnóstico , Reação em Cadeia da Polimerase/métodos , Polimorfismo de Nucleotídeo Único , Kit de Reagentes para Diagnóstico , Adulto , Genótipo , Humanos , Reprodutibilidade dos Testes , Análise de Sequência de DNA
8.
Hum Genet ; 120(6): 779-88, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17120047

RESUMO

Persistence or non-persistence of lactase expression into adult life is a polymorphic trait that has been attributed to a single nucleotide polymorphism (C-13910T) in an enhancer element 13.9 kb upstream of the lactase gene (LCT). The -13910*T allele occurs at very high frequency in northern Europeans as part of a very long haplotype (known as A), and promotes binding of the transcription factor Oct-1. However, -13910*T is at very low frequency in many African milk drinking pastoralist groups where lactase persistence phenotype has been reported at high frequency. We report here for the first time, a cohort study of lactose digester and non-digester Sudanese volunteers and show there is no association of -13910*T or the A haplotype with lactase persistence. We support this finding with new genotype/phenotype frequency comparisons in pastoralist groups of eastern African and Middle Eastern origin. Resequencing revealed three new SNPs in close proximity to -13910*T, two of which are within the Oct-1 binding site. The most frequent of these (-13915*G) is associated with lactose tolerance in the cohort study, providing evidence for a cis-acting effect. Despite its location, -13915*G abolishes, rather than enhances Oct-1 binding, indicating that this particular interaction is unlikely to be involved in lactase persistence. This study reveals the complexity of this phenotypic polymorphism and highlights the limitations of C-13910T as a diagnostic test for lactase persistence status, at least for people with non-European ancestry.


Assuntos
Lactase/genética , Intolerância à Lactose/enzimologia , Intolerância à Lactose/genética , Polimorfismo de Nucleotídeo Único , Adulto , África , Sequência de Bases , Sítios de Ligação/genética , Estudos de Coortes , DNA/genética , DNA/metabolismo , Sondas de DNA/genética , Elementos Facilitadores Genéticos , Etnicidade/genética , Frequência do Gene , Genótipo , Haplótipos , Humanos , Íntrons , Oriente Médio , Fator 1 de Transcrição de Octâmero/metabolismo , Fenótipo , Homologia de Sequência do Ácido Nucleico
9.
J Biol Chem ; 280(52): 42863-76, 2005 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-16227627

RESUMO

The proto-oncoprotein SYT is involved in the unique translocation t(X;18) found in synovial sarcoma SYT-SSX fusions. SYT has a conserved N-terminal domain (SNH domain) that interacts with the human paralog of Drosophila Brahma (hBRM) and Brahma-related gene 1 (BRG1) chromatin remodeling proteins and a C-terminal transactivating sequence rich in glutamine, proline, glycine, and tyrosine (QPGY domain). Here we reported the isolation of the ribonucleoprotein SYT-interacting protein/co-activator activator (SIP/CoAA), which specifically binds the QPGY domain of SYT and also the SYT-SSX2 translocation fusion. SIP/CoAA is a general nuclear co-activator and an RNA splicing modulator that contains two RNA recognition motifs and multiple hexapeptide repeats. We showed that the region consisting of the hexapeptide motif (YQ domain) is similar to the hexapeptide repeat domain found in EWS and in TLS/FUS family proteins. The YQ domain also resembles the QPGY region of SYT itself and like all these other domains acts as a transcriptional activator in reporter assays. Most interestingly, the last 84 amino acids adjacent to YQ down-modulate by 25-fold the YQ transactivation of the reporter gene, and both domains are important for SIP/CoAA binding to SYT. In addition, SYT acts together with SIP/CoAA in stimulating estrogen and glucocorticoid receptor-dependent transcriptional activation. Activation is hormone-dependent and requires functional hBRM and/or BRG1. The stimulation is strongly reduced if the N-terminal region of hBRM/BRG1 (amino acids 1-211) is deleted. This region encompasses the SNF11 binding domain (amino acids 156-211), which interacts specifically with SYT in vivo and in vitro.


Assuntos
Proteínas de Ciclo Celular/química , Núcleo Celular/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/química , Proteínas de Neoplasias/química , Proteínas Proto-Oncogênicas/metabolismo , Proteína EWS de Ligação a RNA/química , Proteína FUS de Ligação a RNA/química , Proteínas de Ligação a RNA/química , Proteínas Repressoras/química , Proteínas Repressoras/metabolismo , Motivos de Aminoácidos , Sequência de Aminoácidos , Animais , Células COS , Linhagem Celular , Linhagem Celular Tumoral , Chlorocebus aethiops , Cromatina/química , Clonagem Molecular , Citoplasma/metabolismo , DNA Complementar/metabolismo , Regulação para Baixo , Drosophila , Biblioteca Gênica , Glutamina/química , Glutationa Transferase/metabolismo , Glicina/química , Hormônios/metabolismo , Humanos , Immunoblotting , Imunoprecipitação , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Ligantes , Modelos Biológicos , Dados de Sequência Molecular , Plasmídeos/metabolismo , Prolina/química , Ligação Proteica , Estrutura Terciária de Proteína , Proteínas Proto-Oncogênicas/química , Splicing de RNA , Proteínas Recombinantes de Fusão/química , Sarcoma Sinovial/metabolismo , Homologia de Sequência de Aminoácidos , Fatores de Processamento de Serina-Arginina , Transcrição Gênica , Ativação Transcricional , Transfecção , Translocação Genética , Técnicas do Sistema de Duplo-Híbrido , Tirosina/química
10.
Oncogene ; 22(50): 8156-67, 2003 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-14603256

RESUMO

Many studies have now established that the SWI/SNF chromatin remodelling complexes are involved in activation and repression of a variety of genes. In mammalian cells, these complexes contain the BRM and BRG1 helicase-like proteins that are thought to be responsible for nucleosome remodelling. The proto-oncoprotein SYT, involved in the unique translocation t(X;18) found in synovial sarcoma, is known to interact with human BRM (hBRM), thus providing a link between chromatin remodelling factors and human cancer. In this work, we address how SYT interacts with hBRM and BRG1. We demonstrate that the conserved N-terminal SNH domain of SYT, which is also present in the oncoproteins SYT-SSX, binds to both hBRM and BRG1. We have also found that in vivo the C-terminus transactivation QPGY region of SYT can interact with itself. This results in an amplified interaction with hBRM and highlights a possible regulatory function of this domain in cells.


Assuntos
Cromatina/genética , Sequência Conservada , Neurotensina/genética , Proteínas/genética , Sequência de Aminoácidos , Animais , Células COS , Cromatina/metabolismo , Humanos , Neurotensina/metabolismo , Estrutura Terciária de Proteína , Proteínas/metabolismo , Proteínas Proto-Oncogênicas , Proteínas Repressoras , Fatores de Transcrição/metabolismo , Peptídeo Intestinal Vasoativo/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...